Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

The Relationship Between Preoperative Serum Ionized Calcium, Vitamin D, and Postoperative Bleeding After Major Cardiac Surgery

Adrian Stef, Constantin Bodolea, Aurelia Georgeta Solomonean, Nadina Tintiuc, Alexandru Oprea, Oana Antal, Gabriel Cismaru and Emanuel Palade
Life 15 (9) 1460 (2025)
https://doi.org/10.3390/life15091460

Reoperation for bleeding after cardiac surgery

Vincent M. De La Porte, Gregory R. A. De Meyer, Tom Schepens, Walter Verbrugghe, Steven Laga, Mathias Allegaert, Pieter Mertens, Inez Rodrigus and Philippe G. Jorens
Acta Chirurgica Belgica 122 (5) 312 (2022)
https://doi.org/10.1080/00015458.2020.1847463

Comparison of the Quality of Life After Conventional Versus Off-Pump Coronary Artery Bypass Surgery

Emmanouil I. Kapetanakis, Sotiris C. Stamou, Kathleen R. Petro, Peter C. Hill, Steven W. Boyce, Ammar S. Bafi and Paul J. Corso
Journal of Cardiac Surgery 23 (2) 120 (2008)
https://doi.org/10.1111/j.1540-8191.2008.00590.x

Management of Antiplatelet Therapy for Minimization of Bleeding Risk Before Cardiac Surgery

Kyle A. Weant, Jeremy F. Flynn and Wendell S. Akers
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (11) 1616 (2006)
https://doi.org/10.1592/phco.26.11.1616

Aortic dissection and hypothermic arrest in a Jehovah’s Witness patient: a case for recombinant factor VIIa?

Jenifer Ballen, Michael Raabe and Brian Muirhead
Canadian Journal of Anesthesia/Journal canadien d'anesthésie 53 (4) 353 (2006)
https://doi.org/10.1007/BF03022498

Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy

Henry Ekert, Christian Brizard, Robert Eyers, Andrew Cochrane and Robert Henning
Blood Coagulation & Fibrinolysis 17 (5) 389 (2006)
https://doi.org/10.1097/01.mbc.0000233369.03358.c1

Off-Pump Myocardial Revascularization in a Diabetic Patient with Severe Hemophilia B and Impaired Left Ventricular Function: Hematological and Operative Strategies

Daniel Grandmougin, Maria-Christina Delolme, Jacqueline Reynaud and Xavier Barral
Journal of Cardiac Surgery 20 (4) 366 (2005)
https://doi.org/10.1111/j.1540-8191.2005.2004108.x

Safety of Recombinant Human Factor XIII in a Cynomolgus Monkey Model of Extracorporeal Blood Circulation

R. Ponce, K. Armstrong, K. Andrews, J. Hensler, K. Waggie, J. Heffernan, T. Reynolds and M. Rogge
Toxicologic Pathology 33 (6) 702 (2005)
https://doi.org/10.1080/15459620500330625

Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass

Viren N. Naik, C. David Mazer, David A. Latter, Jerome M. Teitel and Gregory M. T. Hare
Canadian Journal of Anesthesia/Journal canadien d'anesthésie 50 (6) 599 (2003)
https://doi.org/10.1007/BF03018648

Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible?

Michaela Wilhelmi, Ulrich Franke, Tina Cohnert, Petra Weber, Jörg Kaukemüller, Stefan Fischer, Thorsten Wahlers and Axel Haverich
European Journal of Cardio-Thoracic Surgery 19 (5) 657 (2001)
https://doi.org/10.1016/S1010-7940(01)00648-0